Seres Therapeutics, Inc.MCRBNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+59.7%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+59.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
10.4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025103.39%
2024-6.13%
202361.61%
2022-223.71%
202135.99%
20209.96%
201948.91%
2018-9.90%
20173.93%
20161.29%